BioSpace News Archive

BioForest

EndoGastric Solutions Debuts EsophyX Z+ Device for Transoral Incisionless Fundoplication (TIF) Procedures

New EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes..

November 29, 2017

·

5 min read

Job Trends

BioTalent Canada Announces an Additional $2.3M in Wage Subsidies to Place 200 New Graduates into ‘Green’ Jobs

The federally-funded program will provide $2.3 million in wage subsidies to facilitate over 200 new placements over the next two years.

November 29, 2017

·

2 min read

Drug Development

Aeglea BioTherapeutics Doses First Pediatric Patient with Arginase 1 Deficiency in its Phase I/II Trial with Pegzilarginase (AEB1102)

Clinical agreement reached with FDA to enable pediatric dosing.

November 29, 2017

·

5 min read

Drug Development

Protalix BioTherapeutics Completes Enrollment in Phase II Clinical Trial of OPRX-106 in Patients With Ulcerative Colitis

The Company expects to report top-line results from this study in the first quarter of 2018.

November 29, 2017

·

5 min read

Drug Development

U.S. FDA Grants Fast Track Designation for Idera Pharmaceuticals’ IMO-2125 in Combination with Ipilimumab for Treatment of PD-1 Refractory Metastatic Melanoma

FDA’s Fast Track program is designed to expedite the development and review of drugs and biologics to treat serious or life-threatening conditions.

November 29, 2017

·

6 min read

Deals

Emerald Health Therapeutics Acquires Shares of Vanc Pharmaceuticals

Each whole warrant entitles the holder thereof to purchase one additional Share for a period of 60 months at an exercise price of $0.20.

November 29, 2017

·

4 min read

Policy

ProQR Receives Orphan Drug Designation From EMA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa

DEB is a rare genetic disease that can lead to severe blistering of the skin resulting in high treatment burden and poor quality of life for patients.

November 29, 2017

·

5 min read

Nordic Nanovector: Notice of Extraordinary General Meeting

The Board of Directors of Nordic Nanovector call for an Extraordinary General Meeting to be held at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo on 20 December 2017 at 10:30 CET.

November 29, 2017

·

2 min read

Biotech Beach

Scientists at TSRI and Synthorx Create the First Semi-Synthetic Organism to Encode and Translate Expanded Genetic Information Into a Novel Protein With Different Non-Natural Amino Acids

Synthorx announced today that scientists at TSRI and the company, guided by Floyd Romesberg, Ph.D., have developed the first semi-synthetic organism that can store and retrieve increased genetic information.

November 29, 2017

·

4 min read

Policy

Pillar Biosciences Announces ISO 13485: 2016 Certification

The first Pillar Biosciences assay produced under this QMS is the recently-launched ONCO/REVEAL BRCA 1/2 panel targeting the entire coding region of the BRCA genes.

November 29, 2017

·

1 min read